TrialAnti-cancer drugs2017

Docetaxel and mitoxantrone before radical prostatectomy in men with high-risk prostate cancer: 10-year follow-up and immune correlates.

Colin P Bergstrom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.